Literature DB >> 3165066

Italian experience regarding the prevention of Duchenne and Becker muscular dystrophies.

G Romeo1, M Devoto, N Archidiacono, A Ferlini, L Roncuzzi, M A Melis, E Paderi, M Ferrari, S Tedeschi, G Galluzzi.   

Abstract

The indirect approach to carrier detection and prenatal diagnosis of Duchenne and Becker muscular dystrophies based on the study of DNA polymorphisms closely linked to this gene has been followed by five Italian laboratories in the study of 106 pedigrees. Out of 354 women studied up to 1 May 1987, 147 were identified as carriers because of pedigree information and/or of increased creatine phosphokinase (CPK) values. Of the remaining 207, 184 could be assigned to three arbitrarily defined risk categories (low, intermediate and high) using linkage analysis. This disaggregation of women at risk is clearly more useful than that defined before DNA analysis, in which the same 184 women could be assigned only to the low or intermediate risk categories. Prenatal diagnosis was theoretically possible in 90% of carrier women, and was actually performed in 14 pregnancies, which led to the identification of four affected male foetuses, one also having Down syndrome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3165066     DOI: 10.1007/bf00496422

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

1.  Is nebulin the defective gene product in Duchenne muscular dystrophy?

Authors:  D S Wood; M Zeviani; A Prelle; E Bonilla; G Salviati; A F Miranda; S DiMauro; L P Rowland
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

2.  Prenatal diagnosis and detection of carriers with DNA probes in Duchenne's muscular dystrophy.

Authors:  B T Darras; J F Harper; U Francke
Journal:  N Engl J Med       Date:  1987-04-16       Impact factor: 91.245

3.  Mapping of X-linked Becker muscular dystrophy through crossovers identified by DNA polymorphisms and by haplotype characterization in somatic cell hybrids.

Authors:  L Roncuzzi; S Fadda; M Mochi; L Prosperi; S Sangiorgi; R Santamaria; D Sbarra; D Besana; L Morandi; M Rocchi
Journal:  Am J Hum Genet       Date:  1985-03       Impact factor: 11.025

4.  Nebulin and titin expression in Duchenne muscular dystrophy appears normal.

Authors:  D Fürst; R Nave; M Osborn; K Weber; A Bardosi; N Archidiacono; M Ferro; V Romano; G Romeo
Journal:  FEBS Lett       Date:  1987-11-16       Impact factor: 4.124

5.  Congenital adrenal hypoplasia, myopathy, and glycerol kinase deficiency: molecular genetic evidence for deletions.

Authors:  U Francke; J F Harper; B T Darras; J M Cowan; E R McCabe; A Kohlschütter; W K Seltzer; F Saito; J Goto; J P Harpey
Journal:  Am J Hum Genet       Date:  1987-03       Impact factor: 11.025

6.  Expression of an X-linked muscular dystrophy in a female due to translocation involving Xp21 and non-random inactivation of the normal X chromosome.

Authors:  C Verellen-Dumoulin; M Freund; R De Meyer; C Laterre; J Frédéric; M W Thompson; V D Markovic; R G Worton
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

7.  Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene.

Authors:  A P Monaco; R L Neve; C Colletti-Feener; C J Bertelson; D M Kurnit; L M Kunkel
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

8.  Definitive localization of Becker muscular dystrophy in Xp by linkage to a cluster of DNA polymorphisms (DXS43 and DXS9).

Authors:  S Fadda; M Mochi; L Roncuzzi; S Sangiorgi; D Sbarra; M Zatz; G Romeo
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

9.  Origin of new mutations in Duchenne muscular dystrophy.

Authors:  L Roncuzzi; A Ferlini; A Pirozzi; G Romeo
Journal:  Hum Genet       Date:  1986-12       Impact factor: 4.132

10.  Linkage studies in Duchenne and Becker muscular dystrophies.

Authors:  A Walker; K Hart; C Cole; S Hodgson; L Johnson; V Dubowitz; M Bobrow
Journal:  J Med Genet       Date:  1986-12       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.